Evaluation of prescription practices in rheumatoid arthritis at the rheumatology clinic in a tertiary care teaching hospital in Uttarakhand: A cross-sectional study.
CAM
RA
complimentary alternative medicine therapy
disease modifying anti-rheumatic drug (DMARDs)
drug utilization study in RA
prescription pattern
rheumatoid arthritis therapy
Journal
Journal of family medicine and primary care
ISSN: 2249-4863
Titre abrégé: J Family Med Prim Care
Pays: India
ID NLM: 101610082
Informations de publication
Date de publication:
Feb 2021
Feb 2021
Historique:
received:
06
07
2020
revised:
12
09
2020
accepted:
12
10
2020
entrez:
27
5
2021
pubmed:
28
5
2021
medline:
28
5
2021
Statut:
ppublish
Résumé
This study was aimed to analyze the prescription pattern of disease modifying anti-rheumatic drug (DMARD) therapy in patients with rheumatoid arthritis (RA) in a tertiary care teaching hospital in Uttarakhand, India. This cross-sectional study was conducted in 150 RA patients who were given DMARD therapy. Patient's demographic details, drugs prescribed with their dosage and administration routes and the usage of complementary and alternative medicine (CAM) therapy were recorded to study the prescription pattern. Overall, 4 DMARDs were prescribed in all the studied patients: Methotrexate ( Our study concludes that the most commonly prescribed DMARDs in our setting, to patients of RA, in descending order of frequency were methotrexate, followed by hydroxychloroquine, leflunomide and lastly adalimumab. A total of five adjuvant medications were commonly prescribed to all patients. There was a high prevalence of self-medicated CAM therapy in the majority of these patients.
Identifiants
pubmed: 34041071
doi: 10.4103/jfmpc.jfmpc_1366_20
pii: JFMPC-10-745
pmc: PMC8138383
doi:
Types de publication
Journal Article
Langues
eng
Pagination
745-751Informations de copyright
Copyright: © 2021 Journal of Family Medicine and Primary Care.
Déclaration de conflit d'intérêts
There are no conflicts of interest.
Références
Singapore Med J. 2012 Aug;53(8):532-6
pubmed: 22941131
Arthritis Care Res (Hoboken). 2020 Apr;72(4):461-488
pubmed: 32090466
Arthritis Care Res (Hoboken). 2012 May;64(5):625-39
pubmed: 22473917
Reumatol Clin. 2009 Nov-Dec;5(6):252-8
pubmed: 21794625
Cleve Clin J Med. 1994 Jul-Aug;61(4):276-84
pubmed: 7923746
Ther Adv Endocrinol Metab. 2012 Dec;3(6):181-7
pubmed: 23323190
Nat Rev Rheumatol. 2020 Apr;16(4):239-246
pubmed: 32076129
Clin Dev Immunol. 2013;2013:160123
pubmed: 24348674
Rheumatology (Oxford). 2014 Oct;53(10):1742-51
pubmed: 24729402
Lancet. 2002 Apr 6;359(9313):1173-7
pubmed: 11955534
Ann Rheum Dis. 2010 Jun;69(6):1010-4
pubmed: 20448288
Autoimmun Rev. 2004 Mar;3(3):193-8
pubmed: 15110231
PLoS One. 2016 Mar 17;11(3):e0148791
pubmed: 26987073
Open Access Rheumatol. 2017 Mar 31;9:67-79
pubmed: 28435338
Clin Rheumatol. 2017 Aug;36(8):1715-1720
pubmed: 28634699
Ann Rheum Dis. 2008 Jun;67(6):815-22
pubmed: 17878209
East Afr Med J. 2009 May;86(5):204-11
pubmed: 20084988
Curr Opin Rheumatol. 2007 May;19(3):272-6
pubmed: 17414954
Arthritis Rheumatol. 2016 Jan;68(1):1-26
pubmed: 26545940
Caspian J Intern Med. 2012 Summer;3(3):445-6
pubmed: 25202438